Funder: National Institutes of Health
Due Dates: June 16, 2025 | October 14, 2025 | February 17, 2026 | June 15, 2026 | October 14, 2026
Funding Amounts: Up to $100,000/year (K99 phase, salary) + $30,000/year (research costs); up to $249,000/year (R00 phase, total costs); max 5 years (2 years K99, 3 years R00)
Summary: Supports early-stage postdocs in cancer research to transition rapidly to independent, tenure-track faculty positions; clinical trial leadership not allowed.
Key Information: Each institution may nominate only one candidate per scientific area per cycle; strict 2-year postdoc eligibility window; no independent clinical trials permitted.